Navigation Links
GeoVax Labs, Inc. Announces Results of 2009 Annual Shareholders Meeting
Date:6/23/2009

based in Seattle, Washington. The HVTN, funded through a cooperative agreement with the National Institutes of Health (NIH), is the largest worldwide clinical trials program dedicated to the development and testing of AIDS vaccines. Preclinical work enabling evaluation of GeoVax DNA and MVA vaccines was funded and supported by NIAID, which provided additional support to GeoVax AIDS vaccine development program with a $17 million IPCAVD grant awarded in late 2007.

Safe Harbor Statement

All statements in this news release, not statements of historical fact, are forward-looking statements. These statements are based on expectations and assumptions on the date of this press release and are subject to numerous risks and uncertainties which could cause actual results to differ materially from those described in the forward-looking statements. Risks and uncertainties include, but are not limited to, whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a timely manner, GeoVax's vaccines will be safe for human use, GeoVax's vaccines will effectively prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete vaccine development, there is development of competitive products that may be more effective or easier to use than GeoVax's products, and other factors over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking statements, and does not intend to do so. Certain matters discussed in this news release are forward-looking statements involving certain risks and uncertainties including, without limitation, risks detailed in the Company's Securities and Exchange Commission filings and reports.


'/>"/>
SOURCE GeoVax Labs, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
2. GeoVax Labs, Inc. Comments on Discontinuance of Mercks HIV Vaccine Trial
3. Excellent Results Received from GeoVaxs Full-Dose HIV/AIDS Vaccine Trial
4. GeoVax Labs, Inc. Third Quarter Financial Results and Operational Update
5. GeoVax Labs, Inc. Selects Financial Relations Board as Investor Relations Counsel
6. GeoVax Labs, Inc. Selected by Georgia Bio as 2008 Deal of the Year Award Winner in Life Sciences Industry
7. Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
8. GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
9. GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
10. GeoVax Secures $10 Million Financing Commitment
11. GeoVax Reports Progress on Its AIDS Vaccine Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)...  Accuray Incorporated (Nasdaq: ARAY ), announced today ... the Jefferies 2015 Healthcare Conference in New ... 2:30pm ET.   A live webcast of ... page of the Company,s website at http://www.accuray.com/investors . ... one hour after the conclusion of the live presentation ...
(Date:5/26/2015)... , May 26, 2015 Connected health ... diverse devices and workflows, aiding diagnosis, monitoring and ... infrastructure to be efficient, stakeholders must first ensure ... Logo - http://photos.prnewswire.com/prnh/20150526/218313LOGO ... Healthcare and Medical Device Connectivity and Interoperability, finds ...
(Date:5/26/2015)... Columbia , May 26, 2015  InMed ... today that it has filed a provisional patent ... Office ("USPTO") relating to the treatment of Epidermolysis ... cannabinoid compounds developed by InMed. ... Scientific Officer, commented, "We are excited to file ...
Breaking Medicine Technology:Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 2Interoperability among Connected Medical Devices Can Potentially Transform Healthcare 3InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 2InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 3
... One of the biggest challenges faced by healthcare ... preference items (PPI), such as orthopedic implants, cardiac stents, pacemakers ... most expensive items that hospitals buy. GHX will present strategies ... 2010 Annual Conference & Exhibition, to be held Aug. ...
... Technologies Corp. (Nasdaq: BSTC ), a biopharmaceutical company developing first in ... and live audio webcast at 8:30am EDT on August ... corporate highlights. , , ... participate in the conference call, please dial 800-860-2442 (domestic) or 412-858-4600 (international). ...
Cached Medicine Technology:GHX to Present Strategies to Optimize Procurement, Especially of Physician Preference Items, at Annual AHRMM Conference 2GHX to Present Strategies to Optimize Procurement, Especially of Physician Preference Items, at Annual AHRMM Conference 3BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010 2BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2010 Financial Results on August 6, 2010 3
(Date:5/26/2015)... SC (PRWEB) May 26, 2015 On May ... by Oceans 6 salesman and distributor Dwayne Windfall. At the ... food supply company that has some unique characteristics with it, ... the food business?” Windfall replies saying, “I was reading the ... ad that said they were looking for a person with ...
(Date:5/26/2015)... Pasadena porcelain veneers dentist, Dr. ... cosmetic treatments. Cosmetic dentistry is becoming increasingly popular in ... are committed to providing you with the highest level ... and a smile of a lifetime … We work ... to change your life,” explains Dr. Martirosyan’s team. “Giving ...
(Date:5/26/2015)... USA (PRWEB) May 26, 2015 Based ... site, AnyTranscription has undertaken a comprehensive upgrade of its ... in user experience. To thank users for their feedback ... this five minute trial transcription service promotion. ... from May 26 to June 9 this year. During ...
(Date:5/26/2015)... 2015 Adenna, Inc ., worldwide ... excited to announce the launch of Enov8 ... made of polyethylene (PE) and approved by the U.S. ... , The Enov8 glove might look like ... mixing salads but our proprietary formula and production technology ...
(Date:5/26/2015)... (PRWEB) May 26, 2015 Learning ZoneXpress ... line, Nutrition Education Cards . These cards have ... engaging photography and simple, easy-to-read text, these new educational ... . They offer practical nutrition tips and suggestions to ... titles available are: , + MyPlate: Eat for a ...
Breaking Medicine News(10 mins):Health News:My Positive Perspective Broadcasts Episode with Oceans 6 to Discuss Their Role in Helping the Community 2Health News:Pasadena Porcelain Veneers Expert, Marine Martirosyan DDS, is Now Offering Complimentary Dental Cleaning with Cosmetic Treatments 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 2Health News:Enjoy AnyTranscription’s First-class Audio/Video Transcription Service for Just $0.01 3Health News:Enov8® Exam Glove by Adenna® Approved by U.S. FDA 2Health News:Learning ZoneXpress Introduces New Educational Resource for WIC, SNAP-Ed, and EFNEP 2
... Ohio, Dec. 10 PartsSource, the nation,s leading,supplier ... has,been recognized as a 2007 Pillar Award winner ... companies that have distinguished themselves,through leading by example, ... "My initial vision for PartsSource was that ...
... be held Thursday, January 17, at ... 3:00 p.m. Eastern Time ... CRDC ) today announced that leading cardiac surgeons from The Heart,Hospital ... off-pump coronary artery bypass graft (CABG) procedure as,well as a port-access ...
... Study suggests it results in poor screening, prevention efforts , ... States may be less likely to report a family history ... prevention strategies for that group of patients, a new study ... Cancer , Dr. Heather Orom, of the Barbara Ann ...
... Science University Cancer Institute researcher Jeff Tyner, Ph.D., has created ... therapy in acute myeloid leukemia using an assay that yields ... at the American Society of Hematology annual meeting in Atlanta, ... This functional assay, called RAPID, because it rapidly delivers ...
... (Pink Sheets: HRAL) --,HearAtLast Holdings, Inc. is proud ... Wal-Mart Canada (NYSE: WMT ) to open its ... located at 255 Silver Linden,Dr. in Richmond Hill, Ontario. ... December 8, 2007. This expansion is a direct result ...
... signature standard being adopted worldwide by, pharmaceutical and healthcare organizations ... ... digital identities, CHICAGO, Dec. 10 Aladdin Knowledge ... software DRM and content security, today announced that the,Aladdin eToken ...
Cached Medicine News:Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 2Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 3Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 4Health News:Cardica Announces Live Webcast Demonstrating Breakthrough Device to Facilitate Beating Heart and Robotic Coronary Revascularization Surgery 5Health News:Immigrants Less Likely to Report Family History of Cancer 2Health News:OHSU Cancer Institute researcher develops test for targeted therapy in acute myeloid leukemia 2Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 2Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 3Health News:HearAtLast Continues Expansion Announcing Opening of New Clinic Location in Sam's Club in Richmond Hill, Ontario 4Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 2Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 3Health News:Aladdin eToken First Strong Authentication Device to Achieve Certification from the SAFE-BioPharma Association 4
Inquire...
Sealing Mat for 96-well, 2.0ml, Deep Well, Square Available Sterile...
Silicone Compression Mat, Bulk...
MicroAmp Full Plate Covers, which are manufactured from PCR-compatible rubber, are non-sterile, autoclavable and guaranteed reusable up to five times....
Medicine Products: